F-STAR THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of F-star Therapeutics, Inc. – FSTX – Lawyer Box


NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of F-star Therapeutics, Inc. (NasdaqCM: FSTX) to invoX Pharma. Under the terms of the proposed transaction, shareholders of F-star will receive only $7.12 in cash for each share of F-star that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues ​​the Company.

If you believe that this transaction undervalues ​​the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis .kahn@ksfcounsel.com) toll free at any time at 855-768-1857, or visit to learn more.

To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.

Contacts

Kahn Swick & Foti, LLC

Lewis S. Kahn

lewis.kahn@ksfcounsel.com
855-768-1857





Soruce : https://www.lawyer-monthly.com/2022/06/f-star-therapeutics-investor-alert-by-the-former-attorney-general-of-louisiana-kahn-swick-foti-llc-investigates-adequacy-of-price-and-process-in-proposed-sale-of-f-star-therapeutics-inc-fstx/

Leave a Reply

Your email address will not be published.